- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
13 result(s) found for: Potassium Channel.
Displaying page 1 of 1.
EudraCT Number: 2014-000605-12 | Sponsor Protocol Number: notapplicable1 | Start Date*: 2014-06-13 |
Sponsor Name: | ||
Full Title: Thiazide diuretics versus calcium channel blockers for the treatment of calcineurin inhibitor-induced hypertension in patients with psoriasis or eczema: a single-center randomized cross-over trial. | ||
Medical condition: Hypertension, induced by the use of a Calcineurin Inhibitor (CNI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004704-35 | Sponsor Protocol Number: NL39417.078.12 | Start Date*: 2012-11-22 |
Sponsor Name: | ||
Full Title: Thiazide diuretics versus calcium channel blockers for the treatment of tacrolimus-induced hypertension in dermatology patients: a single-center randomized cross-over trial. | ||
Medical condition: Hypertension, induced by the use of a Calcineurin Inhibitor (CNI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002538-32 | Sponsor Protocol Number: MY-1-2015 | Start Date*: 2015-10-26 | |||||||||||
Sponsor Name:Medicinsk Forskningsafsnit, Regionshospitalet Holstebro (Department of Medical Research, Regional Hospital Holstebro) | |||||||||||||
Full Title: THE EFFECT OF ACYL-GHRELIN ON SODIUM REABSORPTION VIA ENAC IN HEALTHY VOLUNTEERS IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY | |||||||||||||
Medical condition: The physiological responses to Acyl-ghrelin-injection on the sodium reabsorption via ENaC in healthy subjects. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001250-91 | Sponsor Protocol Number: GV-002.001 | Start Date*: 2005-10-04 |
Sponsor Name:GenVec, Inc. | ||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA-Guided/MYOSTAR Catheter in "No Option" Patients with Cla... | ||
Medical condition: Moderate to severe angina pectoris due to advanced coronary artery disease (CAD). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) AT (Completed) DE (Completed) GB (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002438-34 | Sponsor Protocol Number: FAM1 | Start Date*: 2020-08-19 | |||||||||||
Sponsor Name:Department of Neurology, Odense University Hospital | |||||||||||||
Full Title: Fampridine for treatment of residual neurological deficits in patients treated with immunoglobulins for chronic inflammatory demyelinating polyneuropathy | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023979-25 | Sponsor Protocol Number: 2010/353 | Start Date*: 2011-01-03 | ||||||||||||||||
Sponsor Name:Department of Nephrology | ||||||||||||||||||
Full Title: Role of renal and systemic vascular resistance for progression of chronic kidney disease | ||||||||||||||||||
Medical condition: We want to investigate whether increased vasodilitation ( angiotensin converting enzyme inhibitor and calcium channel blocker) compared to standard treatment ( beta-blocker and angiotensin convert... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001851-29 | Sponsor Protocol Number: BAY2253651/19038 | Start Date*: 2018-07-25 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: Randomized, multi-center, double-blind, placebo-controlled, group-comparison study to investigate safety, tolerability and pharmacodynamics of BAY2253651 after administration of a single nasal dose... | |||||||||||||
Medical condition: Obstructive sleep Apnea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001579-35 | Sponsor Protocol Number: KBP5074-2-001 | Start Date*: 2019-08-07 | ||||||||||||||||
Sponsor Name:KBP BioSciences Co., Ltd. | ||||||||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Pharmacokinetics of KBP-5074 in Patients with Moderate-to-Severe Chronic Kidney Disea... | ||||||||||||||||||
Medical condition: Moderate to Severe Chronic Kidney Disease and uncontrolled hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004236-38 | Sponsor Protocol Number: 12250 | Start Date*: 2017-01-24 |
Sponsor Name:University of Oxford | ||
Full Title: OPtimising Treatment for MIld Systolic hypertension in the Elderly: a randomised controlled trial | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004130-15 | Sponsor Protocol Number: CRC-AGA-M-A-11 | Start Date*: 2014-06-03 | |||||||||||
Sponsor Name:Charité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science | |||||||||||||
Full Title: Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopecia | |||||||||||||
Medical condition: Androgenetic Alopecia Hamilton-Norwood IIIv-IV male patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003221-29 | Sponsor Protocol Number: XPF-008-201 | Start Date*: 2020-03-12 | |||||||||||
Sponsor Name:Xenon Pharmaceuticals Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open-label Ex... | |||||||||||||
Medical condition: Adult focal (partial onset) epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004691-44 | Sponsor Protocol Number: CA187-017 | Start Date*: 2009-04-21 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Double-Blind, Randomized, Parallel, Two-Arm Phase II Trial of BMS-690514 versus Erlotinib in Previously Chemotherapy Treated Non-Small Cell Lung Cancer Patients Estudio Fase II doble ciego, aleat... | |||||||||||||
Medical condition: Progressive or recurrent non-small cell lung cancer (NSCLC) after treatment with one to two lines of cytotoxic chemotherapy cáncer de pulmón no microcítico progresivo o recurrente tras tratamiento ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005397-34 | Sponsor Protocol Number: Issue1 | Start Date*: 2012-02-24 | |||||||||||||||||||||
Sponsor Name:University Hospital Bristol NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Xenon and cooling therapy in babies at high risk of brain injury following poor condition at birth: Randomised pilot study. (CoolXenon2 study) | |||||||||||||||||||||||
Medical condition: Neonatal hypoxia-ischaemia (HI). There is no exact MedDRA term for this. The closest MedDRA terms matching this are neonatal asphyxia and neonatal hypoxia. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.